BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 15454139)

  • 21. Ex vivo sentinel lymph node mapping in colon cancer: improving the accuracy of pathologic staging?
    Smith J; Hwang H; Wiseman KW; Filipenko D; Phang PT
    Am J Surg; 2006 May; 191(5):665-8. PubMed ID: 16647356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of radioisotope combined with isosulfan Blue dye is not superior to radioisotope alone for the identification of sentinel lymph nodes in patients with breast cancer.
    Bines S; Kopkash K; Ali A; Fogg L; Wool N
    Surgery; 2008 Oct; 144(4):606-9; discussion 609-10. PubMed ID: 18847645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
    Foster D; Choy N; Porter C; Ahmed S; Wapnir I
    J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer.
    Povoski SP; Olsen JO; Young DC; Clarke J; Burak WE; Walker MJ; Carson WE; Yee LD; Agnese DM; Pozderac RV; Hall NC; Farrar WB
    Ann Surg Oncol; 2006 Nov; 13(11):1412-21. PubMed ID: 16957969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial.
    Rodier JF; Velten M; Wilt M; Martel P; Ferron G; Vaini-Elies V; Mignotte H; Brémond A; Classe JM; Dravet F; Routiot T; de Lara CT; Avril A; Lorimier G; Fondrinier E; Houvenaeghel G; Avigdor S
    J Clin Oncol; 2007 Aug; 25(24):3664-9. PubMed ID: 17485709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of sentinel node mapping for cancer of the colon: 'to map or not to map".
    Thomas KA; Lechner J; Shen P; Waters GS; Geisinger KR; Levine EA
    Am Surg; 2006 Jul; 72(7):606-11; discussion 611-2. PubMed ID: 16875082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between concordance of tracers, order of harvest, and presence of metastases in sentinel lymph nodes with breast cancer.
    Wada N; Imoto S; Yamauchi C; Hasebe T; Ochiai A; Ebihara S
    Ann Surg Oncol; 2005 Jun; 12(6):497-503. PubMed ID: 15864480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
    Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
    Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
    Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
    Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Learning curves and certification for breast cancer lymphatic mapping.
    Bass SS; Cox CE; Reintgen DS
    Surg Oncol Clin N Am; 1999 Jul; 8(3):497-509. PubMed ID: 10448692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of sentinel lymph node in patients with breast cancer].
    Chen J; Wang H; Zhang H
    Zhonghua Wai Ke Za Zhi; 2002 Mar; 40(3):164-7. PubMed ID: 11955405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence.
    Murawa D; Hirche C; Dresel S; Hünerbein M
    Br J Surg; 2009 Nov; 96(11):1289-94. PubMed ID: 19847873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer.
    Shimazu K; Tamaki Y; Taguchi T; Motomura K; Inaji H; Koyama H; Kasugai T; Wada A; Noguchi S
    Ann Surg; 2003 Mar; 237(3):390-8. PubMed ID: 12616124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Added value of blue dye in sentinel node biopsy for breast cancer.
    Snoj M; Golouh R; Movrin-Stanovnik T; Vidergar-Kralj B
    J Exp Clin Cancer Res; 2003 Dec; 22(4):551-5. PubMed ID: 15053296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy.
    Noguchi M; Inokuchi M; Zen Y
    J Surg Oncol; 2009 Aug; 100(2):100-5. PubMed ID: 19479943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer.
    Lawson LL; Sandler M; Martin W; Beauchamp RD; Kelley MC
    Am Surg; 2004 Dec; 70(12):1050-5; discussion 1055-6. PubMed ID: 15663043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study.
    McMasters KM; Wong SL; Martin RC; Chao C; Tuttle TM; Noyes RD; Carlson DJ; Laidley AL; McGlothin TQ; Ley PB; Brown CM; Glaser RL; Pennington RE; Turk PS; Simpson D; Cerrito PB; Edwards MJ;
    Ann Surg; 2001 May; 233(5):676-87. PubMed ID: 11360892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subareolar versus peritumoral injection for location of the sentinel lymph node.
    Klimberg VS; Rubio IT; Henry R; Cowan C; Colvert M; Korourian S
    Ann Surg; 1999 Jun; 229(6):860-4; discussion 864-5. PubMed ID: 10363900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficiency of lymphatic mapping by intradermal injection of vital blue dye for sentinel node identification in T1-2 N0-1 M0 stage breast cancer patients].
    Kokhreidze I; Nemsadze G; Gersamia G; Dzagnidze G; Janjalia M
    Georgian Med News; 2005 Apr; (121):7-10. PubMed ID: 15908713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concordance between peri-areolar blue dye and peri-incisional radiotracer injections for sentinel node mapping in patients with a history of primary breast cancer excisonal biopsy.
    Mehrabibahar M; Azizi S; Jangjoo A; Saremi E; Kakhki VR; Sadeghi R; Chicken DW; Keshtgar M
    Acta Chir Belg; 2014; 114(1):31-3. PubMed ID: 24720135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.